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Viruses have many epitopes to induce immune responses from both innate and
adaptive immune systems. Especially, viral double-stranded RNA (dsRNA),
single-stranded RNA (ssRNA), unmethylated CpG motif and outer structural
proteins stimulate intrinsic cellular defenses and further innate immune response
1-5
(Fig. 1). These viral ligands are recognized by Toll-like receptor (TLR) during the
virus replication. TLR is one of the most common pattern recognition receptor
(PRR) of intrinsic cellular defenses that recognize pathogen-associated molecular
patterns (PAMPs) such as bacterial or viral components. TLRs are composed of
three general components, such as extracellular domains (ECDs), transmembrane
domains, and cytoplasmic tails which contain Toll/interleukin-1 receptor (TIR)
for signaling.
6-8 TLR ECDs contain 19-27 leucine-rich repeats (LRRs) and
cysteine-flanking regions, which form horseshoe-like structure to recognize each
specific type of PAMPs for TLR. The TIR of cytoplasmic tail of TIR mediates
downstream signal transductions.
7,9 As a means for early recognition of microbial
pathogens, TLRs are expressed on various cells,
10 their recognition signals leading
to induction of innate immune responses. 
Recognition of these various viral components is possible because of their N-
terminal ECD which contain 18-25 tandem copies of a short (24 residues) motives
which are known as the LRR.
5 Up to date, 13 human TLRs are discovered, and
most of their functions have been elucidated. There are 5 major sensors for viral
infections, such as TLR2, TLR3, TLR4, TLR7, TLR8 and TLR9. TLR3 recognizes
viral dsRNA, TLR2 and TLR4 detect viral structural proteins or glycoproteins,
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TLR7 and TLR8 recognize viral ssRNA, and TLR9 senses
viral CpG motif during replication of many viruses (Table
1). Therefore, these TLR constitute a powerful sensor
system to detect viral components.
11 In fact, each TLR has
different signal transduction pathway, either MyD88-
dependent or TIR domain-containing adaptor inducing
interferons (IFNs)-β (TRIF)-dependent. Only TLR3 uses
TRIF-dependent pathway (Fig. 2), whereas TLR7, TLR8
and TLR9 use MyD88-dependent pathway. On the other
hand, TLR4 particularly uses both TRIF-dependent and
MyD88-dependent pathways. Lower steps of these path-
ways, including transcription activators such as interferon
regulatory factor (IRF)-3, 5, 7 and nuclear factor-κ B (NF-κ
B), are activated. The NF-κ B is one of the major transcri-
ption factors that regulates various innate immune res-
ponses, such as inflammation.
12-15 The IRF families are
known to induce type I IFNs,
16,17 and type I IFNs secreted
make individual cells to be resistant against viral infection.
Focusing on antiviral activities, these activated transcription
factors are essential for induction of type I IFNs, especially
IFN-α and IFN-β.
11 There are several isotypes of type I
interferon, such as IFN-α, IFN-β, IFN-δ , IFN-ω and IFN-τ .
18
Especially, IFN-α and IFN-β have been shown to be potent
antiviral cytokines. They not only inhibit viral replication
directly, but also activate immune effector cells.
18 In innate
immunity, type I IFNs have been demonstrated to play a
crucial role in dendritic cell maturation, differentiation, B
cell activation, priming of primary antibody responses, and
memory CD8+ T cell proliferation, and to prolong long-
term survival.
19 Moreover, IFN-α/β‚ induce GTPase-like
myxovirus-resistance protein (Mx) protein which inhibits
virus replication.
20 Through positive feedback processes,
IFN-αis able to enhance many TLRs, such as TLR3, TLR4,
TLR7, and TLR8.
11 These aspects of viral replication and
invasion are reviewed herein.
Almost all viruses are composed of nucleic acid and viral
proteins. They are detected by specialized sensors such as
TLRs, one of the PRR. TLRs are localized on the cell
surface or endosomal membrane. Therefore, attachment of
a virus is sensed by external TLRs, especially TLR2 and 4
on the cell surface, while invasion of a virus is recognized
by internal TLRs (TLR3, 7, 8 and 9). Each step of viral
replication produces many PAMPs, such as single- or
double-strand RNA, viral nuclear proteins, envelope
proteins and glycoproteins. Signaling from TLRs sensing
TOLL-LIKE RECEPTORS SENSING 
VIRAL LIGANDS
Fig. 1. Pathogen-associated molecular patterns and TLRs. There are several TLRs with their ligands. These PAMPs are microbial and viral
components.  Especially, TLR2, TLR3, TLR4, TLR7, TLR8 and TLR9 recognize viral ligands. TLR3 recognizes viral dsRNA, TLR2 and TLR4 detect viral
glycoproteins, both TLR7 and TLR8 recognize viral ssRNA, and TLR9 senses viral CpG motif during replication of many viruses. TLR, Toll-like
receptor; PAMP, pathogen-associated molecular pattern; dsRNA, double-strand RNA; ssRNA, single-stranded RNA; HSV, Herpes simplex virus;
CMV, cytomegalovirus; HCV, hepatitis C Virus; WNV, West Nile virus; RSV, Respiratory Syncytial virus; MMTV, Mouse mammary tumor virus.can activate IRF3, 5, 7 or NF-κ B pathway, resulting in
induction of type I IFNs. The secreted type I IFNs make
neighbor cells to express various antiviral proteins, such as
myxovirus-resistance protein (Mx) GTPase, ribonuclease L
(RNase L), RNA-dependent protein kinase (PKR), Oligo-
adenylate synthetase (OAS), and Interferon stimulated
gene (ISG). 
TLR3
Double-stranded RNA (dsRNA), which is a replication
intermediate of several viruses, sensitize innate immune
system through TLR3. They are mostly enveloped RNA
viruses like Respiratory Syncytial virus (RSV),
21 influenza
A virus,
22 and West Nile virus (WNV).
2 Double-stranded
RNA is observed during most RNA virus replications, and
is correlated with endosomal expression of TLR3. Role of
TLR3 is experimentally proved using an artificial dsRNA
and TLR3 knockout mice. Synthetic dsRNA polyinosinic-
polycytidylic acid (poly(I:C)) has an immunostimulatory
activity similar to dsRNA,
23 and TLR3-deficient mice have
been found to have their response to dsRNA impaired.
15
This sensing ability against viral dsRNA is due to molecular
structure of TLR3. Recently, TLR3-ECD has been shown
to resemble a horseshoe-shaped solenoid of 23 LRRs, with
each LRR forming one turn of the solenoid. As a dsRNA
binding motif of TLR3, H539 and N541 are conserved in
living organisms, ranging from zebrafish to humans: H539
coordinates a phosphate group, whereas N541 forms a
hydrogen bond to the 2’OH of the ribose. When longer
dsRNAs are recognized by TLR3, binding of TLR3s to
longer dsRNAs forms oligomer morphology. This model
can explain the mechanism of why most oligomer TLR3
easily accommodates the formation of a TIR dimers on the
endosomal membrane;
5 particularly, dsRNA has never
been detected in non-infected cells, while detected only in
virus-infected cells. Therefore, TLR3 is regarded as a
major PRR against virus in animal cells. In fact, respiratory
epithelial cells over-express TLR3 when infected by
influenza A virus, and cells are then able to detect viruses’
infection signals and able to acquire resistance.
24
TLR2 
TLR2 is located on the cell surface and recognizes extra-
cellular ligands. TLR2 forms heterodimers with either
TLR1 or TLR6. Several viruses, such as Herpes simplex
virus (HSV), cytomegalovirus (CMV), hepatitis C virus
(HCV) and measles virus, induce type I IFNs and pro-
inflammatory cytokines via TLR2 signaling.
25-29 HSV
infection induces TLR2-mediated pro-inflammatory cyto-
kines and type I IFNs production.
26 It seems likely that
viral outer glycoprotein acts as ligand for TLR2. However,
HSV’s four essential viral glycoproteins, such as glycopro-
tein B (gB), D (gD), H (gH), and L (gL), have recently been
found to induce innate immune recognition in TLR2-
independent manner.
27 However, HSV’s ligand for TLR2
is still largely unclear. CMV is also recognized by TLR2
and CD14. Recognition signal triggers inflammatory
cytokines and type I IFNs production. Especially, TLR2 is
required for NF-κ B activation in response to CMV infec-
tion.
28 Viral core protein and nonstructural protein (NS) 3
of HCV are potent ligands for TLR2. Amino acid sequences
in the regions of 2-122 in core and 1450-1643 in NS3 are
required for recognition by TLR2.
29 Hemagglutinin (H)
protein of wild type measles virus can induce proinflam-
matory cytokines such as interleukin (IL)-6 by TLR2
activation. Inactivated virus by heating or ultraviolet (UV)
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Table 1.TLRs and Its’ Viral Ligands
Virus Ligand PRRs References
measles virus Hemagglutinin (H) protein 25
HSV Unknown
TLR2
26, 27
CMV Envelope protein 28
HCV Core protein, NS3 proteins 29
WNV 2
RSV dsRNA TLR3 21
Influenza A virus 22
RSV F protein 3
HSV Unknown TLR4 32, 33
MMTV Envelope protein 34, 35
Dengue virus
ssRNA TLR7, 8 1
Influenza virus
HSV CpG TLR9 4, 39, 40
HSV, Herpes simplex virus; CMV, cytomegalovirus; HCV, hepatitis C Virus; WNV, West Nile virus; RSV, Respiratory Syncytial virus; MMTV, 
Mouse mammary tumor virus.inactivation can also induce TLR2-dependent signaling.
On the other hand, point mutation in H protein of measles
virus affects TLR2 signaling.
25 Moreover, TLR2 is able to
induce intrinsic cellular defenses by sensing these viral
ligands, resulting in the production of type I IFNs.
TLR4
Similar to TLR2, TLR4 is also located on the cell surface
and forms heterodimers with either TLR5, which presuma-
bly enhances its activity, or TLR1, which inhibits its
activity.
3 Otherwise, MD-2 is essential for signaling of
TLR4. N-linked carbohydrate seems to have critical role in
interaction between MD-2 and TLR4. In human, MD-2
contains 2 N-glycosylated sites, while TLR4 contains 9 N-
linked glycosylated sites. The site-directed mutagenesis
studies show that these glycosylated sites are cross-linking
positions between MD-2, TLR4 and its ligands.
30 The
major ligand of TLR4 is lipopolysaccharides (LPS) deriv-
ed from the outer membrane of Gram-negative bacteria,
however, there is also an evidence to indicate that TLR4
recognizes also some viral components, such as viral
glycoproteins on viral particles. It is known that RSV infec-
tion induces up-regulation of TLR4 on airway epithelial
cells,
31 and a fusion (F) protein of RSV, one of the glyco-
proteins, sensitizes TLR4. Since, purified RSV F protein
can activate MD-2-dependent TLR4 signaling pathway,
therefore, combination of TLR4 with MD-2 appears to be
indispensable for immune response against viruses.
3
Furthermore, among the TLRs 1 through 13, only TLR4
showed an altered expression after HCV infection of
human B cells. Even though HCV’s agonist for TLR4 has
not yet been clearly identified, it is certain that HCV has a
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Fig. 2. TLR signaling upon intrinsic cellular defenses. Viral ligands are recognized by each TLRs, TLR2 and 4 which are localized on the cellular
membranes, TLR3, TLR7, and TLR8, TLR9 are expressed on the endosomal membrane. Only TLR3 uses MyD88 independent signaling pathway,
while other TLRs use MyD88 dependent pathway. Through these pathways, transcription factors (IRF-3, 5, 6 and NF-κ B) are activated. Because
they contain nuclear localization signal (NLS), they are able to enter the nucleus. Then, these transcription activators are thought to play an
important role in the regulation of pro-inflammatory cytokines and type I IFNs. TLR, Toll-like receptor; IRF, interferon regulatory factor; IFN,
interferon; dsRNA, double-strand RNA; ssRNA, single-stranded RNA.ligand against TLR4. When a siRNA targeting TLR4 is
applied, HCV-induced cytokine production is specifically
inhibited.
32 Indeed, HCV is used as an agonist for TLRs,
especially TLR4.
33 Also, mammary tumor virus (MMTV)
induces TLR4-dependent innate immune responses,
confirmed by using TLR4 knockout mice. There was a
large amount of cytokine released from TLR4-sufficient
mice, whereas these was not from TLR4 knockout mice.
34
An envelope glycoprotein SU is regarded as a legend for
TLR4,
35 therefore, extracellular TLR4 seems to play a criti-
cal role in intrinsic cellular defense against virus infection.
TLR7 and TLR8
Both TLR7 and TLR8 sense the viral infection by recogni-
zing uridine-rich single-stranded RNA. Similar to TLR3,
TLR7 and TLR8 are localized on endosomal inner mem-
brane.
12 Release of RNA genome into the endosome is
required for TLR7 and TLR8 to recognize viral replication,
uncrating, or degradation (Fig. 2). As one of the most
sensitive anti-viral receptors, both TLR7 and TLR8 recog-
nize almost all RNA viruses, such as dengue virus and
influenza virus.
1 Interestingly in human system, type I IFN
which are produced by plasmacytoid dendritic cells (PDCs)
specifically induce TLR7 and MyD88 expression in naive
B cells. This induction makes the cells to have more sensi-
tivity against virus invasions.
36 Among numerous ssRNAs in
the cytoplasm, including mRNAs, viral ssRNAs and other
oligonucleotide RNAs, only viral ssRNA and nucleic acid
agonists can be recognized by the presence of uridine ribo-
nucleotide and initiate innate immune system via TLR7.
37
Similarly, guanosine (G)- and uridine (U)-rich ssRNA
oligonucleotides induce signals via TLR8.
38 These results,
therefore, suggest that the specific region of viral ssRNA is
the physiological ligand for TLR7 and TLR8.
TLR9
TLR 9 in the endosomal membrane plays a central role in
the host defense against viral infection.
39 It is a receptor for
sensing unmethylated CpG sequence motif, which is found
abundantly in some viral genomes, such as dsDNA virus
and HSV.
4 In fact, CpG binds to TLR9 via ionic interaction
with negatively charged phosphate backbone of DNA.
40 In
addition, the presence of dinucleotide at 5’-end is critical
for receptor recognition more than that at 3’-end.
40 When
animal cells are infected with dsDNA virus, viral dsDNA
is recognized by TLR9 and induces the production of type I
IFNs through signal transduction pathway. Interestingly,
among the TLRs, only TLR7 and TLR9 are expressed in
putative lymphoid DC precursors, although immature
myeloid DCs and myeloid DC precursors don’t exhibit
these patterns in human cells. Therefore, putative lymphoid
DC precursors are also called as type I IFNs (alpha/beta/
omega)-producing cells (IPCs), because of their IFN-
producing ability. This ability may be related with TLR9
expression, allowing the cells to recognize virus infection
and induce type I IFNs.
39
TLR signaling is mediated by adapter proteins and protein
kinases, ultimately leading to the activation of IFN regula-
tory factor, IRF3, 5 and 7, or NF-κ B family.
11,16,41 Because
these factors have nuclear localization signals (NLSs), they
are able to enter the nucleus. As a major transcription factor
for anti-viral activity, NF-κ B is thought to play an important
role in the induction of pro-inflammatory molecules, such
as IL-1β, and tumor necrosis factor α (TNF-α), upon
cellular responses against the virus infection.
42 IRF5 is a
strong transcription activator for IFN-α production,
41 and
IRF7 can induce IFN-α and also IFN-β preferentially.
43
Production of type I IFNs is possible because of transloca-
tion of these transcription activators into the nucleus, lead-
ing to DNA binding at promoters containing interferon-
stimulated response element (ISRE). IRF3, -5 or -7 under-
goes conformational changes because of phosphorylation
(P) at Ser/Thr residues in the carboxyl terminus,
44,45 and
this leads to C-terminal auto-inhibition and exposes both
DNA binding domain (DBD) and interaction domain
regions (IAD).
45 Because of this conformational change,
IRF3 or IRF7 is now capable of forming heterodimer with
IRF5. Interestingly, whereas heterodimer of IRF5 and
IRF3 still has a function of transcription activator, IRF5/
IRF7 heterodimerization does not lead to a functional
complex binding to the IFN-α promoter. These results
suggest that IRF5 may be a part of the regulatory networks
(Fig. 2).
45
NF-κ B activation induces the synthesis of type I IFNs, IL-
1β and TNF-α, which exert antiviral and immune stimul-
atory activities (Fig. 2). Moreover, IRF families-dependent
pathway leads to the secretion of type I IFNs such as IFN-
αand -β.
46 Secreted type I IFNs bind to its receptor, IFNAR,
which is composed of subunits IFNAR-1 and IFNAR-2,
and make an auto- or paracrine activation.
47 Then, signal
transduction pathway is operated by phosphorylation of
signal transducer and activator of transcription 1 and 2
(STAT1 and STAT2) molecules by Janus tyrosine kinases
(JAK).
48 Phosphorylated STAT1 and STAT2 form hetero-
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TYPE I INTERFERONS PRODUCTION VIA
TOLL-LIKE RECEPTOR SIGNALING
TYPE I INTERFERON PRODUCTION 
AND ANTIVIRAL ACTIVITIESdimer, and the latter is translocated into nucleus and then
bound to ISRE. Antiviral effectors such as Mx, PKR,
RNase L, OAS and ISG are transcriptionally activated to
be expressed (Fig. 3).
49
Mx GTPase
Mx GTPase, one of the IFN-inducible antiviral effectors,
has a strict dependency on strong control of the type I IFNs
for their expression.
50 In IFN-deficient mice, Mx is also
deficient. Similar to the receptor of type I IFNs, IFNAR
deficient mice are also deficient for Mx. As previously
stated, Mx plays an essential role in host defense against
various viruses, especially influenza A virus.
51 In support
of the above notion, evidence indicates that Mx-neutralizing
antibody treatment allows orthomyxoviruses to replicate.
Therefore, Mx has a critical antiviral activity against
viruses. Mx consists of three domains such as N-terminal
GTPase domain, middle linker domain, and C-terminal
GTPase effector domain (GED). Each domains are highly
conserved among the species. Central interacting domain
(CID) and a C-terminal leucine zipper (LZ) can recognize
viral components, and has to go through polymerization.
The GED which has a critical role in polymer formation
has been revealed by experiments with Mx variants
52: Mx
captures viral nucleocapsid proteins in the cytoplasm and
blocks their movement into the nucleus, thereby controll-
ing viral replication by inhibition of nuclear import and
further their assembly (Fig. 3).
53
RNA-dependent protein kinase
RNA-dependent protein kinase (PKR) is also known as
IFN-inducible protein. Active PKR phosphorylates euka-
ryotic initiation factor 2α (eIFα) and leads to inhibition of
viral gene translation, leading to regulated viral protein
synthesis.
54 In particular, phosphorylation of eIF2α is
required for resistance against HSVs
55 and rotavirus.
56 PKR
is activated by binding of viral dsRNA through two N-
terminal dsRNA binding motifs (dsRBM), resulting in
homodimerization between viral dsRNA and dsRBM.
57 As
a ligand for PKR, most viral dsRNAs are synthesized in
virus-infected cells when viral replication cycle is operated.
In RNA viruses, influenza virus for an example, has replica-
tive forms that are intermediate for the synthesis of new
genomic RNA copies. In DNA viruses, vaccinia virus,
adenovirus or herpes simplex virus for examples, has open
reading frames (ORFs) in opposite orientation, so that they
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Fig. 3. Antiviral activities of type I IFNs inducible effectors. Type I IFNs induce variable antiviral effectors such as Mx, PKR, RNase L, OAS and ISG.
Mx GTPase captures viral nucleocapsid proteins to prevents virus assembly.
53PKR phosphorylates eIF2αleading to inhibition of gene translation.
54
RNase L is activated by OAS, and breaks down viral RNAs.
61 ISG induces IFN-β gene expression by preventing degradation of IRF3.
68  IFN,
interferon; Mx, myxovirus-resistance protein GTPase; PKR, RNA-dependent protein kinase; OAS, oligo-adenylate synthetase; RNase L,
ribonuclease L; ISG, interferon stimulated gene; EIF2α, eukaryotic initiation factor 2α.Virus Infection Induced Antiviral Type I Interferon via Toll-Like Receptor Signaling
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are able to produce overlapping mRNA transcripts that can
fold to form dsRNA structures, thus offering ligands for
PKR.
58 IFN-α transgenic mice show an elevated expression
level of PKR, and mice lacking a functional PKR pathway
are resistant no longer to infection of HSV-2 (Fig. 3).
59 
Oligo-adenylate synthetase and RNase L 
Oligo-adenylate synthetase (OAS) and RNase L are also
IFN-inducible antiviral effectors, and they exhibit remar-
kable antiviral activities against HSV type I when treated
with type I IFNs.
60 Activity of RNase L is strongly affected
by OAS, and activated RNase L leads to viral RNA degra-
dation as intrinsic cellular defenses.
61 OAS protein is accu-
mulated in the cytoplasm as an inactive monomer, and
dsRNAs containing the motif of NNWWNNNNNNNN
NWGN activates OAS.
62 Activated OAS converts ATP
into 2’,5’-linked oligomers of adenosine (2-5A).
63 Binding
of 2-5A to RNase L triggers dimerization of monomers
through their kinase-like domains, thereby enabling RNase
L to cleave viral RNAs. It is possible to degrade viral RNA,
because RNase L is able to cleave the viral ssRNA at the
position of 39 of UpUp or UpAp sequences during the
virus infection. On the other hand, RNase L cleaves some
self mRNAs and produces small RNAs which act as a
ligand for intracellular receptors such as RIG-1 and MDA-
5. These receptors also induce type I IFNs and make it
possible to acquire antiviral activities. In fact, RNase L-
deficient cells are more permissive to viruses such as para-
myxovirus, Sendai virus, picorna virus, encephalomyo-
carditis virus (EMCV), West Nile virus and Coxsackie
virus B4 (Fig. 3).
64,65 
Interferon-stimulated gene
ISG has a role of antiviral activities, and there are several
subtypes such as ISG15, ISG17 and ISG20.
20,66,67 ISG15
can be conjugated to target proteins through its C-terminal
LRLRGG motif which is referred to ISGylation. However,
the consequence of ISGylation of target proteins and its
cellular functions remain largely unclear.
68 Although most
of the ISG’s activities are not yet clearly elucidated, ISG15
has been reported to inhibit degradation of IRF3 by viral
components. IRF3 induces IFN-β gene expression and
activates host immune systems,
69 and ISG15 deficient mice
are susceptible for infection with several viruses, including
influenza viruses, Sindbis virus and HSV-1.
68 Therefore, it
is important to identify the role of ISGylation in the type I
IFNs-mediated antiviral response (Fig. 3).
Intrinsic cellular defenses arise when PAMPs are recognized
by PRRs. Then, innate immune response is rapidly acti-
vated to eliminate pathogens and activate adaptive immu-
nities. If there are no activities of innate immune response,
no other individuals can be free from invading pathogens.
In innate immunity, TLR is an essential component to
resist the invasion of pathogens. Especially, TLR2, TLR3,
TLR4, TLR7, TLR8 and TLR9 sense viral ligands and
give a warning for viral infection by signaling pathway.
When viruses infect any cells, attachment entry, uncoating,
viral genome replication, viral protein production, their
assembly and release are provoked by the following proce-
dure: TLRs detect viral components on each steps of viral
infection cycle. It is the reason why TLRs are expressed on
the specific location and have different ECDs for each
viral ligand. As an outcome of TLR signaling, type I IFNs
play antiviral activities through inducing viral replication
inhibitory components. IFN-α and IFN-β affect not only
sensitized cells, but also neighbor cells, to maintain antiviral
states by auto- or paracrine modes. Then, IFN-inducible
antiviral effectors such as Mx GTPase, PKR, RNase L,
OAS and ISG are produced, and they prevent virus repli-
cation. Till now, the signaling pathway of TLR which
leads to IFN production has been considered to be impor-
tant for antiviral activities because of virus to inhibit IFN
production. Nevertheless, more studies are needed to
enhance our immune systems and eliminate viral pathogens.
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